. "Kane, Garvan C." . "[5C14368C42C7]" . "0931-0509" . "RIV/00216208:11150/08:00208826" . . "Nephrology, Dialysis, Transplantation" . . . "Garovic, Vesna D." . "RIV/00216208:11150/08:00208826!RIV10-MSM-11150___" . . "Lee, Christine U." . "Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes" . "Kalnick\u00E1, Dita" . "Percutaneous angiography with iodinated contrast in patients with chronic kidney disease carries a risk of contrast nephropathy, which is independently associated with increased mortality. Gadolinium contrast is a potential safe alternative to iodinated contrast for percutaneous transluminal renal angioplasty (PTRA). We compared the outcomes in patients with serum creatinine (Cr) >/= 176 micromol/L (2 mg/dL), who had either gadolinium (n = 57), iodinated (n = 68) or a combination of gadolinium and iodinated-contrast-enhanced (n = 38) PTRA. All patients had similar degrees of pre-procedural renal insufficiency. According to our results, gadolinium contrast is (when compared to iodinated contrast) associated with a significantly lower incidence of contrast nephropathy and early progression to end-stage renal disease (ESRD) in patients with pre-existing chronic kidney disease. The risk of fibrosing dermopathy remains to be established." . "Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes" . . "11150" . "23" . . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "Textor, Stephen C." . "4" . "Percutaneous angiography with iodinated contrast in patients with chronic kidney disease carries a risk of contrast nephropathy, which is independently associated with increased mortality. Gadolinium contrast is a potential safe alternative to iodinated contrast for percutaneous transluminal renal angioplasty (PTRA). We compared the outcomes in patients with serum creatinine (Cr) >/= 176 micromol/L (2 mg/dL), who had either gadolinium (n = 57), iodinated (n = 68) or a combination of gadolinium and iodinated-contrast-enhanced (n = 38) PTRA. All patients had similar degrees of pre-procedural renal insufficiency. According to our results, gadolinium contrast is (when compared to iodinated contrast) associated with a significantly lower incidence of contrast nephropathy and early progression to end-stage renal disease (ESRD) in patients with pre-existing chronic kidney disease. The risk of fibrosing dermopathy remains to be established."@en . . "Stanson, Anthony W." . "7"^^ . "S" . "angiography; chronic kidney disease; gadolinium; iodinated contrast"@en . . . . "Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes"@en . "360535" . "Rosenthal, David W." . "Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes"@en . "8"^^ . "000254472400026" . . . "1"^^ .